Anagenics Ltd has released a press release.
Market Update on COVID-19
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Appendix 4D, Half Year Accounts and Presentation
- Cellmids Evolis Patent to be Granted in China
- Appendix 4C and Notes to Appendix 4C
- Key Midkine Antibody Patents Granted in the US and Europe
- Cellmid Reports on QVC Sales
Later from Anagenics
- Response to ASX Query Letter
- Reinstatement to Official Quotation
- Cellmids Shipment of SARS-CoV-2 Tests Received
- Independent Test Results For The Wondfo SARS-CoV-2 Test
- Cellmids Alopecia Patent Allowed in Australia and Japan
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics